Postprandial lipemia as a cardiometabolic risk factor
High levels of fasting circulating triglycerides (TG) represent an independent risk factor for cardiovascular disease. In western countries, however, people spend most time in postprandial conditions, with continuous fluctuation of lipemia due to increased levels of TG-rich lipoproteins (TRLs), incl...
| Main Authors: | Pirillo, A., Norata, Giuseppe, Catapano, A. |
|---|---|
| Format: | Journal Article |
| Published: |
Librapharm
2014
|
| Online Access: | http://hdl.handle.net/20.500.11937/56246 |
Similar Items
Novel Aspects of Nonfasting Lipemia in Relation to Vascular Biology
by: Cabezas, M., et al.
Published: (2012)
by: Cabezas, M., et al.
Published: (2012)
Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?
by: Catapano, A., et al.
Published: (2017)
by: Catapano, A., et al.
Published: (2017)
Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)
by: Catapano, A., et al.
Published: (2017)
High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches
by: Catapano, A., et al.
Published: (2011)
by: Catapano, A., et al.
Published: (2011)
Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)
by: Pirillo, A., et al.
Published: (2016)
LOX-1, OxLDL, and atherosclerosis
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
HDLs, immunity, and atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2011)
by: Norata, Giuseppe, et al.
Published: (2011)
Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)
by: Pirillo, A., et al.
Published: (2015)
Strategies for the use of nonstatin therapies
by: Pirillo, A., et al.
Published: (2017)
by: Pirillo, A., et al.
Published: (2017)
Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
by: Catapano, A., et al.
Published: (2017)
by: Catapano, A., et al.
Published: (2017)
Apolipoprotein C-III: From Pathophysiology to Pharmacology
by: Norata, Giuseppe, et al.
Published: (2015)
by: Norata, Giuseppe, et al.
Published: (2015)
The effects of whey protein on cardiometabolic risk factors
by: Pal, Sebely, et al.
Published: (2013)
by: Pal, Sebely, et al.
Published: (2013)
Emerging role of high density lipoproteins as a player in the immune system
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus
by: Ammirati, E., et al.
Published: (2014)
by: Ammirati, E., et al.
Published: (2014)
HDL: To treat or not to treat?
by: Pirillo, A., et al.
Published: (2014)
by: Pirillo, A., et al.
Published: (2014)
HDL in innate and adaptive immunity
by: Catapano, A., et al.
Published: (2014)
by: Catapano, A., et al.
Published: (2014)
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)
by: Pirillo, A., et al.
Published: (2018)
PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
by: Casula, M., et al.
Published: (2017)
by: Casula, M., et al.
Published: (2017)
Prevalence of cardiometabolic risk factors among Malaysian obese adults
by: Shahadan, Siti Zuhaidah, et al.
Published: (2016)
by: Shahadan, Siti Zuhaidah, et al.
Published: (2016)
Prevalence of cardiometabolic risk factors among Malaysian obese adults
by: Shahadan, Siti Zuhaidah, et al.
Published: (2016)
by: Shahadan, Siti Zuhaidah, et al.
Published: (2016)
Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016)
by: Norata, Giuseppe, et al.
Published: (2016)
Acute exercise improves postprandial cadiovascular risk factors in overweight and obese individuals.
by: Ho, Suleen, et al.
Published: (2011)
by: Ho, Suleen, et al.
Published: (2011)
Neighborhood walkability and cardiometabolic risk factors in australian adults: An observational study
by: Müller-Riemenschneider, F., et al.
Published: (2013)
by: Müller-Riemenschneider, F., et al.
Published: (2013)
Associations of an empirical dietary pattern with cardiometabolic risk factors in Malaysian adolescents
by: Emi, Nor Aishah, et al.
Published: (2020)
by: Emi, Nor Aishah, et al.
Published: (2020)
Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)
by: Norata, Giuseppe, et al.
Published: (2014)
HDL and adaptive immunity: A tale of lipid rafts
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
Leonurine: A new comer in the natural compounds affecting atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
Identification of a dietary pattern associated with greater cardiometabolic risk in adolescence
by: Appannah, Geeta, et al.
Published: (2015)
by: Appannah, Geeta, et al.
Published: (2015)
Increased cardiometabolic risk is associated with increased TV viewing time
by: Wijndaele, K., et al.
Published: (2010)
by: Wijndaele, K., et al.
Published: (2010)
Serum 25-hydroxyvitamin D concentrations and cardiometabolic risk factors in adolescents and young adults
by: Black, Lucinda, et al.
Published: (2016)
by: Black, Lucinda, et al.
Published: (2016)
Patterns of sedentary time and cardiometabolic risk among Canadian adults
by: Carson, V., et al.
Published: (2014)
by: Carson, V., et al.
Published: (2014)
Physical health and cardiometabolic risk markers among the elder people
by: Che Hasan, Muhammad Kamil
Published: (2017)
by: Che Hasan, Muhammad Kamil
Published: (2017)
The CD1d-natural killer T cell axis in atherosclerosis
by: Bondarenko, S., et al.
Published: (2014)
by: Bondarenko, S., et al.
Published: (2014)
Sugar consumption pattern among cardiometabolic risk individuals: a scoping review
by: Chiang, Wan Ling, et al.
Published: (2022)
by: Chiang, Wan Ling, et al.
Published: (2022)
Correlation between framingham risk score and cardiometabolic risk profile in Malaysian obese adults
by: Shahadan, Siti Zuhaidah, et al.
Published: (2016)
by: Shahadan, Siti Zuhaidah, et al.
Published: (2016)
Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia
by: Grigore, L., et al.
Published: (2013)
by: Grigore, L., et al.
Published: (2013)
New therapeutic principles in dyslipidaemia: Focus on LDL and Lp(a) lowering drugs
by: Norata, Giuseppe, et al.
Published: (2013)
by: Norata, Giuseppe, et al.
Published: (2013)
Importance of Cardiometabolic Risk Factors in the Association Between Nonalcoholic Fatty Liver Disease and Arterial Stiffness in Adolescents
by: Huang, R., et al.
Published: (2013)
by: Huang, R., et al.
Published: (2013)
Similar Items
-
Novel Aspects of Nonfasting Lipemia in Relation to Vascular Biology
by: Cabezas, M., et al.
Published: (2012) -
Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?
by: Catapano, A., et al.
Published: (2017) -
Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017) -
High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013) -
Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches
by: Catapano, A., et al.
Published: (2011)